Neuroprotection by propargylamines in Parkinson's disease: Suppression of apoptosis and induction of prosurvival genes

This publication has 47 references indexed in Scilit:

• Enhancing effect of rasagiline on superoxide dismutase and catalase activities in the dopaminergic system in the rat.
  Life Sciences, 2000
• Caspase-3: A vulnerability factor and final effector in apoptotic death of dopaminergic neurons in Parkinson's disease
  Proceedings of the National Academy of Sciences, 2000
• Neuroprotective strategies for basal ganglia degeneration: Parkinson's and Huntington's diseases
  Progress in Neurobiology, 2000
• Apoptosis induced by an endogenous neurotoxin, N-methyl(R)salsolinol, is mediated by activation of caspase 3
  Neuroscience Letters, 1999
• An evaluation of the role of mitochondria in neurodegenerative diseases: mitochondrial mutations and oxidative pathology, protective nuclear responses, and cell death in neurodegeneration
  Brain Research Reviews, 1998
• Increased survival of dopaminergic neurons by rasagiline, a monoamine oxidase B inhibitor
  NeuroReport, 1998
• Inhibition of interleukin 1β converting enzyme family proteases reduces ischemic and excitotoxic neuronal damage
  Proceedings of the National Academy of Sciences, 1997
• (−)Deprenyl increases activities of superoxide dismutase and catalase in striatum but not in hippocampus: The sex and age-related differences in the optimal dose in the rat
  Experimental Neurology, 1992
• Deprenyl suppresses the oxidant stress associated with increased dopamine turnover
  Annals of Neurology, 1989
• TYRAMINE ANTAGONISTIC PROPERTIES OF AGN 1135, AN IRREVERSIBLE INHIBITOR OF MONOAMINE OXIDASE TYPE B
  British Journal of Pharmacology, 1981